Literature DB >> 11961008

Osteopontin synthesis and localization along the human nephron.

Anja Verhulst1, Veerle P Persy1, An R Van Rompay1, Walter A Verstrepen1, Mark F Helbert1, Marc E De Broe1.   

Abstract

In normal human and rat kidneys, osteopontin (OPN) is present at the apical surface of cells in the distal nephron. After ischemic or toxic renal damage in rats, OPN is upregulated in distal tubular cells (DTC) and expressed de novo in perinuclear vesicles in proximal tubular cells (PTC). In the first phase of this study, OPN localization in ischemic human biopsies was compared with that in ischemic rat kidneys. In the second phase, cultures of PTC and DTC were used to investigate human renal OPN synthesis, secretion, and localization. OPN localization in human biopsies after renal ischemia was comparable to that in ischemic rat kidneys. Microscopic and flow cytometric detection of immunofluorescent OPN staining in tubular cell cultures demonstrated strong plasma membrane localization in DTC, whereas mainly perinuclear intracellular expression was observed in PTC. Northern blotting and reverse transcription-PCR demonstrated production of a single OPN mRNA in PTC and DTC. Detection of OPN by Western blotting and enzyme-linked immunosorbent assay demonstrated that PTC and DTC synthesized and secreted the same three molecular mass OPN forms, in comparable amounts. Finally, confocal microscopy demonstrated different staining patterns for endocytotic/lysosomal vesicles and perinuclear OPN; however, perinuclear OPN exhibited colocalization with the Golgi apparatus. In conclusion, human renal OPN localization in cell cultures demonstrated differences between PTC and DTC comparable to those observed after renal ischemia in vivo. Therefore, these cell cultures represented an excellent model for the study of human OPN synthesis, secretion, and localization in PTC versus DTC. It is reported for the first time that intracellular OPN is located in the Golgi apparatus of both PTC and DTC and that PTC and DTC are able to produce and secrete the same OPN isoforms, in comparable amounts.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11961008     DOI: 10.1681/ASN.V1351210

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  7 in total

1.  VHL genetic alteration in CCRCC does not determine de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin.

Authors:  Michelle J Nyhan; Shereen M El Mashad; Tracey R O'Donovan; Sarfraz Ahmad; Chris Collins; Paul Sweeney; Eamonn Rogers; Gerald C O'Sullivan; Sharon L McKenna
Journal:  Cell Oncol (Dordr)       Date:  2011-05-06       Impact factor: 6.730

2.  Matrix Metalloproteinase 20 Co-expression With Dentin Sialophosphoprotein in Human and Monkey Kidneys.

Authors:  Kalu U E Ogbureke; Komal Koli; Geetu Saxena
Journal:  J Histochem Cytochem       Date:  2016-10       Impact factor: 2.479

3.  Osteopontin expression in normal skin and non-melanoma skin tumors.

Authors:  Pi-Ling Chang; Louie Harkins; Yu-Hua Hsieh; Patricia Hicks; Kraisorn Sappayatosok; Somchai Yodsanga; Somporn Swasdison; Ann F Chambers; Craig A Elmets; Kang-Jey Ho
Journal:  J Histochem Cytochem       Date:  2007-10-15       Impact factor: 2.479

4.  Endocytotic uptake of zoledronic acid by tubular cells may explain its renal effects in cancer patients receiving high doses of the compound.

Authors:  Anja Verhulst; Shuting Sun; Charles E McKenna; Patrick C D'Haese
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

5.  Characterisation of Osteopontin in an In Vitro Model of Embryo Implantation.

Authors:  Stéphane C Berneau; Peter T Ruane; Daniel R Brison; Susan J Kimber; Melissa Westwood; John D Aplin
Journal:  Cells       Date:  2019-05-09       Impact factor: 6.600

6.  Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease.

Authors:  Maurizio Bruschi; Simona Granata; Giovanni Candiano; Antonia Fabris; Andrea Petretto; Gian Marco Ghiggeri; Giovanni Gambaro; Gianluigi Zaza
Journal:  Int J Mol Sci       Date:  2019-11-05       Impact factor: 5.923

7.  A novel role for osteopontin in macrophage-mediated amyloid-β clearance in Alzheimer's models.

Authors:  Altan Rentsendorj; Julia Sheyn; Dieu-Trang Fuchs; David Daley; Brenda C Salumbides; Hannah E Schubloom; Nadav J Hart; Songlin Li; Eric Y Hayden; David B Teplow; Keith L Black; Yosef Koronyo; Maya Koronyo-Hamaoui
Journal:  Brain Behav Immun       Date:  2017-08-30       Impact factor: 19.227

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.